ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

ROQ Roquefort Therapeutics Plc

4.75
0.20 (4.40%)
18 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Roquefort Therapeutics Plc ROQ London Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.20 4.40% 4.75 04:28:14
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.55 4.55 4.75 4.75 4.55
más cotizaciones de acciones »
Sector Industrial de la empresa
GENERAL FINANCIAL

Noticias Recientes

Fecha Hora Fuente Noticia
05/4/202406:32ALNCNewsIN BRIEF: Roquefort cancels fundraise after "unusual" stock..
05/4/202401:00UK RNSRoquefort Therapeutics PLC Response to Share Price Movement
11/3/202406:12ALNCNewsRoquefort celebrates "significant milestones" in cancer..
11/3/202402:00UK RNSRoquefort Therapeutics PLC Positive Results: Midkine mRNA..
06/2/202410:50ALNCNewsIN BRIEF: Roquefort hails further MK studies, licence talks..
06/2/202401:00UK RNSRoquefort Therapeutics PLC Operations Update
24/11/202301:00UKREGRoquefort Therapeutics PLC Change of Auditor
06/11/202306:01ALNCNewsRoquefort Therapeutics MK cell programme shows positive..
06/11/202301:00UKREGRoquefort Therapeutics PLC Significant Mesodermal Killer..
27/9/202309:43ALNCNewsEARNINGS: Biome loss widens; Amicorp focused on growth..
27/9/202301:00UKREGRoquefort Therapeutics PLC Interim Results to 30 June 2023
22/9/202305:42RNSNONRoquefort Therapeutics PLC Investor Presentation via..
14/8/202305:07ALNCNewsRoquefort files patent application for mRNA and RNA..
14/8/202301:00UKREGRoquefort Therapeutics PLC Expansion of Patent Portfolio
07/8/202305:04ALNCNewsIN BRIEF: Roquefort announces new sirNA sequences and patent..
07/8/202301:00UKREGRoquefort Therapeutics PLC Development of New Novel siRNA..
02/8/202301:00UKREGRoquefort Therapeutics PLC Director/PDMR Shareholding
12/7/202304:27UKREGRoquefort Therapeutics PLC Director/PDMR Shareholding
29/6/202312:51ALNCNewsTRADING UPDATES: Anpario trading in line, Likewise Group..
29/6/202304:05UKREGRoquefort Therapeutics PLC Results of AGM
29/6/202301:00UKREGRoquefort Therapeutics PLC AGM Statement
27/6/202301:00RNSNONRoquefort Therapeutics PLC Investor Presentation via..
26/6/202310:34UKREGRoquefort Therapeutics PLC Director/PDMR Shareholding
26/6/202304:36UKREGRoquefort Therapeutics PLC Director/PDMR Shareholding
26/6/202304:00UKREGRoquefort Therapeutics PLC Director/PDMR Shareholding
22/6/202314:34ALNCNewsTRADING UPDATES: Plant Health Care announces GBP2.8 million..
22/6/202301:00UKREGRoquefort Therapeutics PLC RNA Medicine Shows In Vitro..
19/6/202306:28ALNCNewsRoquefort Therapeutics celebrates cancer antibody trial..
19/6/202301:00UKREGRoquefort Therapeutics PLC Antibody Program Results & Orphan..
13/6/202305:52ALNCNewsIN BRIEF: Roquefort says anti-cancer mRNA study shows..
13/6/202301:00UKREGRoquefort Therapeutics PLC Anti-Cancer MDK mRNA - Positive..
07/6/202308:41ALNCNewsIN BRIEF: Roquefort Therapeutics suspension on shares lifted
07/6/202304:11UKREGRoquefort Therapeutics PLC Restoration of Trading
06/6/202301:00UKREGRoquefort Therapeutics PLC Notice of Annual General Meeting
05/6/202305:50ALNCNewsRoquefort Therapeutics loss widens as administrative costs..
05/6/202301:00UKREGRoquefort Therapeutics PLC Annual Report & Financial..
02/5/202301:56UKREGRoquefort Therapeutics PLC Suspension of Trading Pending..
02/5/202301:30UKREGOfficial List Suspension - Roquefort Therapeutics plc

Su Consulta Reciente

Delayed Upgrade Clock